[CLS] O
Immunohistochemical O
staining O
was O
positive O
for O
S B
- I
100 I
in O
all O
9 O
cases O
stained O
, O
positive O
for O
HMB B
- I
45 I
in O
9 O
( O
90 O
% O
) O
of O
10 O
, O
and O
negative O
for O
cytokeratin B
in O
all O
9 O
cases O
in O
which O
myxoid O
melanoma O
remained O
in O
the O
block O
after O
previous O
sections O
. O
[SEP] O

[CLS] O
ROCK B
- I
I I
, O
Kinectin B
, O
and O
mDia2 B
can O
bind O
the O
wild O
type O
forms O
of O
both O
RhoA B
and O
Cdc42 B
in O
a O
GTP O
- O
dependent O
manner O
in O
vitro O
. O
[SEP] O

[CLS] O
These O
activities O
are O
all O
required O
for O
stimulation O
of O
cell O
growth O
by O
middle B
- I
T I
and O
activate O
members O
of O
the O
MAP B
kinase I
family I
. O
[SEP] O

[CLS] O
In O
the O
p51 B
subunit I
, O
the O
Cys181 O
side O
- O
chain O
is O
oriented O
in O
a O
similar O
direction O
to O
the O
Tyr181 O
side O
- O
chain O
in O
the O
wild O
- O
type O
complex O
. O
[SEP] O

[CLS] O
A O
prostaglandin O
analogue O
given O
in O
early O
pregnancy O
and O
human B
chorionic I
gonadotropin I
given O
near O
the O
end O
of O
the O
ensuing O
follicular O
phase O
were O
used O
for O
controlling O
the O
reproductive O
cycle O
, O
timing O
oocyte O
collection O
, O
and O
synchronizing O
the O
cycles O
of O
oocyte O
donors O
and O
embryo O
recipients O
. O
[SEP] O

[CLS] O
DNA B
- I
dependent I
protein I
kinase I
( O
DNA B
- I
PK I
) O
consists O
of O
a O
heterodimeric O
protein O
( O
Ku B
) O
and O
a O
large O
catalytic O
subunit O
( O
DNA B
- I
PKcs I
) O
. O
[SEP] O

[CLS] O
Peroxydase B
reaction O
stains O
were O
negative O
, O
chloroacetate B
esterase I
were O
strongly O
positive O
. O
[SEP] O

[CLS] O
Alanine O
substitution O
mutations O
in O
the O
Zta B
activation I
domain I
which O
eliminate O
the O
ability O
of O
Zta B
to O
stimulate O
the O
D B
- I
A I
complex I
were O
examined O
. O
[SEP] O

[CLS] O
Here O
we O
describe O
and O
map O
two O
more O
new O
genes O
identified O
as O
allele O
- O
specific O
suppressors O
that O
compensate O
for O
carboxy O
- O
terminal O
truncation O
of O
PET122 B
. O
[SEP] O

[CLS] O
In O
these O
cases O
, O
greatly O
increased O
human B
chorionic I
gonadotropin I
( O
hCG B
) O
levels O
and O
suppressed O
TSH B
levels O
suggest O
that O
hCG B
has O
thyrotropic O
activity O
. O
[SEP] O

[CLS] O
The O
DNA O
sequence O
encodes O
a O
protein O
of O
1520 O
amino O
acids O
with O
sequence O
homology O
to O
the O
human B
c I
- I
abl I
proto I
- I
oncogene I
product I
, O
beginning O
at O
the O
amino O
terminus O
and O
extending O
656 O
amino O
acids O
through O
the O
region O
essential O
for O
tyrosine B
kinase I
activity O
. O
[SEP] O

[CLS] O
By O
using O
total O
- O
protein O
extracts O
from O
mycelia O
grown O
under O
penicillin O
producing O
conditions O
we O
have O
detected O
a O
DNA O
- O
binding O
activity O
that O
specifically O
shifts O
a O
promoter O
fragment O
located O
between O
- O
654 O
and O
- O
455 O
( O
relative O
to O
IPNS B
tsp I
) O
. O
[SEP] O

[CLS] O
Furthermore O
, O
the O
wide O
distribution O
of O
the O
GFP B
- O
POLO B
protein O
to O
all O
compartments O
of O
the O
mitotic O
apparatus O
provides O
a O
valuable O
tool O
for O
future O
studies O
on O
cell O
cycle O
during O
development O
. O
[SEP] O

[CLS] O
Therefore O
, O
the O
impaired O
floor O
plate O
development O
in O
oep B
mutants I
is O
not O
caused O
by O
the O
absence O
of O
the O
floor B
plate I
inducer I
shh I
. O
[SEP] O

[CLS] O
An O
examination O
of O
the O
properties O
of O
sequences O
surrounding O
ARS1 O
left O
open O
the O
possibility O
that O
ABFI B
enhances O
the O
initiation O
of O
DNA O
replication O
at O
ARS1 O
by O
transcriptional O
activation O
. O
[SEP] O

[CLS] O
Deletion O
of O
the O
apeA B
gene I
, O
either O
with O
or O
without O
deletion O
of O
other O
proteinases O
( O
protease B
IV I
and O
aminopeptidase B
N I
) O
, O
did O
not O
have O
any O
effect O
on O
cell O
growth O
in O
the O
various O
media O
tested O
. O
[SEP] O

[CLS] O
One O
hundred O
units O
/ O
kg O
of O
recombinant B
human I
erythropoietin I
( O
rhEPO B
) O
was O
given O
subcutaneously O
3 O
times O
a O
week O
for O
3 O
weeks O
. O
[SEP] O

[CLS] O
Stromelysin B
- I
1 I
, O
matrix B
metalloproteinase I
- I
3 I
( O
MMP B
- I
3 I
) O
, O
is O
an O
important O
endopeptidase O
selectively O
expressed O
by O
somatic O
cells O
in O
organ O
tissues O
. O
[SEP] O

[CLS] O
This O
enzyme O
is O
designated O
( B
1 I
- I
- I
> I
4 I
) I
- I
beta I
- I
xylan I
endohydrolase I
isoenzyme I
X I
- I
I I
. O
[SEP] O

[CLS] O
In O
a O
PC12 O
cell O
mutant O
that O
is O
deficient O
in O
protein B
kinase I
A I
activity O
( O
AB O
. O
11 O
) O
, O
all O
three O
differentiating O
agents O
were O
unable O
to O
down O
- O
regulate O
nrg B
- I
1 I
mRNA I
. O
[SEP] O

[CLS] O
The O
histamine B
H1 I
receptor I
antagonists O
( O
antihistamines O
) O
are O
an O
important O
class O
of O
medications O
used O
for O
the O
relief O
of O
common O
symptoms O
associated O
with O
hyperhistaminic O
conditions O
occurring O
in O
children O
and O
adults O
. O
[SEP] O

[CLS] O
Significantly O
, O
the O
polymerase O
chain O
reaction O
results O
demonstrated O
that O
gene B
IV I
transcripts I
were O
associated O
with O
hepatic O
polysome O
fractions O
, O
indicating O
their O
active O
utilization O
in O
this O
tissue O
. O
[SEP] O

[CLS] O
Aberrant O
protein O
phosphorylation O
at O
tyrosine O
is O
responsible O
for O
the O
growth O
- O
inhibitory O
action O
of O
pp60v B
- I
src I
expressed O
in O
the O
yeast O
Saccharomyces O
cerevisiae O
. O
[SEP] O

[CLS] O
FTF B
is O
also O
abundantly O
expressed O
in O
the O
pancreas O
and O
may O
exert O
differentiation O
functions O
in O
endodermal O
sublineages O
, O
similar O
to O
SF B
- I
1 I
in O
steroidogenic O
tissues O
. O
[SEP] O

